These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 25823534

  • 1. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction.
    Inthachai T, Lekawanvijit S, Kumfu S, Apaijai N, Pongkan W, Chattipakorn SC, Chattipakorn N.
    Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats.
    Apaijai N, Chinda K, Palee S, Chattipakorn S, Chattipakorn N.
    PLoS One; 2014 Jun; 9(7):e102374. PubMed ID: 25036861
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats.
    Tanajak P, Pintana H, Siri-Angkul N, Khamseekaew J, Apaijai N, Chattipakorn SC, Chattipakorn N.
    J Endocrinol; 2017 Feb; 232(2):189-204. PubMed ID: 27875248
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.
    Hausenloy DJ, Whittington HJ, Wynne AM, Begum SS, Theodorou L, Riksen N, Mocanu MM, Yellon DM.
    Cardiovasc Diabetol; 2013 Oct 22; 12():154. PubMed ID: 24148218
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats.
    Sivasinprasasn S, Tanajak P, Pongkan W, Pratchayasakul W, Chattipakorn SC, Chattipakorn N.
    Sci Rep; 2017 Mar 10; 7():44306. PubMed ID: 28281660
    [Abstract] [Full Text] [Related]

  • 12. Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet.
    Apaijai N, Pintana H, Chattipakorn SC, Chattipakorn N.
    Endocrinology; 2012 Aug 10; 153(8):3878-85. PubMed ID: 22621958
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart.
    Chinda K, Sanit J, Chattipakorn S, Chattipakorn N.
    Diab Vasc Dis Res; 2014 Mar 10; 11(2):75-83. PubMed ID: 24357666
    [Abstract] [Full Text] [Related]

  • 15. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
    Yamaguchi T, Watanabe A, Tanaka M, Shiota M, Osada-Oka M, Sano S, Yoshiyama M, Miura K, Kitajima S, Matsunaga S, Tomita S, Iwao H, Izumi Y.
    J Pharmacol Sci; 2019 Feb 10; 139(2):112-119. PubMed ID: 30638989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.
    Tanajak P, Sa-Nguanmoo P, Apaijai N, Wang X, Liang G, Li X, Jiang C, Chattipakorn SC, Chattipakorn N.
    Cardiovasc Ther; 2017 Aug 10; 35(4):. PubMed ID: 28391633
    [Abstract] [Full Text] [Related]

  • 19. Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury.
    Chinda K, Palee S, Surinkaew S, Phornphutkul M, Chattipakorn S, Chattipakorn N.
    Int J Cardiol; 2013 Jul 31; 167(2):451-7. PubMed ID: 22285447
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.